Uric acid is predictive of cardiovascular mortality and sudden cardiac death in subjects referred for coronary angiography

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 1, 2013, Pages 46-52

  Silbernagel, G ^a   Hoffmann, M M ^b   Grammer, T B ^c   Boehm, B O ^d   Marz W ^c,e,f  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF ULM   (Germany)

^e SYNLAB ACADEMY   (Germany)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

All cause mortality; Cardiovascular mortality; Coronary artery disease; Sudden cardiac death; Uric acid

Indexed keywords

URIC ACID;

ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; RADIOGRAPHY; RISK FACTOR; SUDDEN CARDIAC DEATH;

CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; URIC ACID;

EID: 84872687969     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.02.008     Document Type: Article

References (30)

1. Strazzullo P., Puig J.G. Uric acid and oxidative stress: relative impact on cardiovascular risk?. Nutr Metab Cardiovasc Dis 2007, 17(6):409-414.
2. Feig D.I., Kang D.H., Johnson R.J. Uric acid and cardiovascular risk. N Engl J Med 2008, 359:1811-1821.
3. Fang J., Alderman M.H. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992. JAMA 2000, 283:2404-2410.
4. Niskanen L.K., Laaksonen D.E., Nyyssönen K., Alfthan G., Lakka H.M., Lakka T.A., et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004, 164:1546-1551.
5. Meisinger C., Koenig W., Baumert J., Döring A. Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study. Arterioscler Thromb Vasc Biol 2008, 28:1186-1192.
6. Chen J.H., Chuang S.Y., Chen H.J., Yeh W.T., Pan W.H. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study. Arthritis Rheum 2009, 61:225-232.
7. Zoppini G., Targher G., Negri C., Stoico V., Perrone F., Muggeo M., et al. Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care 2009, 32:1716-1720.
8. Culleton B.F., Larson M.G., Kannel W.B., Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999, 131:7-13.
9. Moriarity J.T., Folsom A.R., Iribarren C., Nieto F.J., Rosamond W.D. Serum uric acid and risk of coronary heart disease: atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 2000, 10:136-143.
10. Strasak A., Ruttmann E., Brant L., Kelleher C., Klenk J., Concin H., et al. VHM&PP Study Group. Serum uric acid and risk of cardiovascular mortality: a prospective long-term study of 83,683 Austrian men. Clin Chem 2008, 54:273-284.
11. Strasak A.M., Kelleher C.C., Brant L.J., Rapp K., Ruttmann E., Concin H., et al. VHM&PP Study Group.Collaborators. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int J Cardiol 2008, 125:232-239.
12. Høieggen A., Alderman M.H., Kjeldsen S.E., Julius S., Devereux R.B., De Faire U., et al. LIFE Study Group. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004, 65:1041-1049.
13. Athyros V.G., Elisaf M., Papageorgiou A.A., Symeonidis A.N., Pehlivanidis A.N., Bouloukos V.I., et al. GREACE Study Collaborative Group. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Am J Kidney Dis 2004, 43:589-599.
14. Winkelmann B.R., Marz W., Boehm B.O., Zotz R., Hager J., Hellstern P., et al. LURIC Study Group (Ludwigshafen Risk and Cardiovascular Health). Rationale and design of the LURIC study - a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2000, 2(1Suppl 1):S1-S73.
15. Friesinger G.C., Page E.E., Ross R.S. Prognostic significance of coronary arteriography. Trans Assoc Am Physicians 1970, 83:78-92.
16. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 1)(29(Suppl):S43-S48. American Diabetes Association.
17. Chugh S.S., Jui J., Gunson K., Stecker E.C., John B.T., Thompson B., et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J Am Coll Cardiol 2004, 44:1268-1275.
18. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
19. Bonora E., Capaldo B., Perin P.C., Del Prato S., De Mattia G., Frittitta L., et al. Group of Italian Scientists of Insulin Resistance (GISIR). Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Nutr Metab Cardiovasc Dis 2008, 18:624-631.
20. Lippi G., Targher G., Montagnana M., Salvagno G.L., Guidi G.C. Hyperuricaemia is associated with increased C-reactive protein concentrations in a large cohort of unselected outpatients. Nutr Metab Cardiovasc Dis 2008, 18(8):e41-e42.
21. Johnson R.J., Perez-Pozo S.E., Sautin Y.Y., Manitius J., Sanchez-Lozada L.G., Feig D.I., et al. Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?. Endocr Rev 2009, 30:96-116.
22. Lin C.S., Lee W.L., Hung Y.J., Lee D.Y., Chen K.F., Chi W.C., et al. Prevalence of hyperuricemia and its association with antihypertensive treatment in hypertensive patients in Taiwan. Int J Cardiol 2010, [Epub ahead of print].
23. Choi H.K., Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007, 116:894-900.
24. So A., Thorens B. Uric acid transport and disease. J Clin Invest 2010, 120:1791-1799.
25. Kang D.H., Park S.K., Lee I.K. Johnson RJ.Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005, 16:3553-3562.
26. Khosla U.M., Zharikov S., Finch J.L., Nakagawa T., Roncal C., Mu W., et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005, 67:1739-1742.
27. Khan F., George J., Wong K., McSwiggan S., Struthers A.D., Belch J.J. The association between serum urate levels and arterial stiffness/endothelial function in stroke survivors. Atherosclerosis 2008, 200:374-379.
28. Kocaman S.A., Sahinarslan A., Cemri M., Timurkaynak T., Boyaci B., Cengel A. Independent relationship of serum uric acid levels with leukocytes and coronary atherosclerotic burden. Nutr Metab Cardiovasc Dis 2009, 19:729-735.
29. Stark K., Reinhard W., Grassl M., Erdmann J., Schunkert H., Illig T., et al. Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease. PLoS One 2009, 4:e7729.
30. Brandstätter A., Kiechl S., Kollerits B., Hunt S.C., Heid I.M., Coassin S., et al. Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabetes Care 2008, 31:1662-1667.